Golden State Equity Partners’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-120
| Closed | -$1.49K | – | 668 |
|
|
2024
Q3 | $1.49K | Buy |
+120
| New | +$1.49K | ﹤0.01% | 722 |
|
|
2022
Q1 | $308K | Hold |
2,790
| – | – | 0.16% | 149 |
|
|
2021
Q4 | $269K | Buy |
2,790
+793
| +40% | +$76.5K | 0.14% | 141 |
|
|
2021
Q3 | $174K | Buy |
1,997
+523
| +35% | +$45.6K | 0.07% | 220 |
|
|
2021
Q2 | $228K | Buy |
1,474
+761
| +107% | +$118K | 0.09% | 215 |
|
|
2021
Q1 | $113K | Buy |
+713
| New | +$113K | 0.06% | 164 |
|